These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25545309)

  • 1. Serum anti-Müllerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Acta Obstet Gynecol Scand; 2015 Mar; 94(3):279-87. PubMed ID: 25545309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
    Nybacka Å; Carlström K; Fabri F; Hellström PM; Hirschberg AL
    Fertil Steril; 2013 Oct; 100(4):1096-102. PubMed ID: 23876536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
    Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.
    Stener-Victorin E; Baghaei F; Holm G; Janson PO; Olivecrona G; Lönn M; Mannerås-Holm L
    Fertil Steril; 2012 Feb; 97(2):501-8. PubMed ID: 22154367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian morphology in polycystic ovary syndrome: estimates from 2D and 3D ultrasound and magnetic resonance imaging and their correlation to anti-Müllerian hormone.
    Nylander M; Frøssing S; Bjerre AH; Chabanova E; Clausen HV; Faber J; Skouby SO
    Acta Radiol; 2017 Aug; 58(8):997-1004. PubMed ID: 28273731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Müllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients.
    Sahmay S; Guralp O; Aydogan B; Cepni I; Oral E; Irez T
    Gynecol Endocrinol; 2013 May; 29(5):440-3. PubMed ID: 23461296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise decreases anti-müllerian hormone in anovulatory overweight women with polycystic ovary syndrome: a pilot study.
    Moran LJ; Harrison CL; Hutchison SK; Stepto NK; Strauss BJ; Teede HJ
    Horm Metab Res; 2011 Dec; 43(13):977-9. PubMed ID: 21989557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome.
    Cui Y; Shi Y; Cui L; Han T; Gao X; Chen ZJ
    Fertil Steril; 2014 Jul; 102(1):230-236.e2. PubMed ID: 24746743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.
    Sahmay S; Atakul N; Oncul M; Tuten A; Aydogan B; Seyisoglu H
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):157-61. PubMed ID: 23806449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
    Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
    Christiansen SC; Eilertsen TB; Vanky E; Carlsen SM
    PLoS One; 2016; 11(1):e0146739. PubMed ID: 26799212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
    Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.